RBC Capital Reiterates Sector Perform on Moderna, Maintains $75 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Luca Issi has reiterated a Sector Perform rating for Moderna (NASDAQ:MRNA) and maintained a price target of $75.
September 19, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
RBC Capital has reiterated its Sector Perform rating for Moderna, maintaining a price target of $75. This suggests a neutral outlook on the stock's performance.
The reiteration of a Sector Perform rating and maintenance of a $75 price target by RBC Capital indicates a neutral stance on Moderna's stock. This suggests that the analyst does not expect significant short-term price movement, either upward or downward, based on current information.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100